Tradestie Institutional Equity Comparison Engine

AHG vs SNYR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SNYR Overall Edge

SNYR Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Synergy CHC Corp. Common Stock (SNYR) driven by superior Valuation, Growth & Margin while AHG counters with relative strength in Momentum & Technical. Fundamentally, AHG trades at N/M Forward P/E with -28.9% operating margin (-12.9% YoY revenue) versus SNYR at 0.6x Forward P/E and -10.3% operating margin (-32.8% YoY). In options structure, AHG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SNYR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SNYR
AHG N/M vs SNYR 0.6x Fwd P/E
Growth & Margin Winner SNYR
Op Margin -28.9% vs -10.3% ยท YoY -12.9% vs -32.8%
Momentum & Technical Winner AHG
1Y -14.3% vs -96.2% ยท 52W Pos 32% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AHG NASDAQ
Akso Health Group ADS
Services-Business Services, Nec
$1.26
-1.56% 1D
Market Cap $1.1B
1M Return +3.28%
1Y Return -14.29%
Forward P/E N/M
Unified AI Score
38.2 / 100 SELL
Tech 20.0 Fund 39.0 Flow 50.0 Mom 40.0
SNYR NASDAQ
Synergy CHC Corp. Common Stock
Medicinal Chemicals & Botanical Products
$0.09
-67.02% 1D
Market Cap $4.1M
1M Return -16.28%
1Y Return -96.15%
Forward P/E 0.6x
Unified AI Score
48.9 / 100 HOLD
Tech 55.0 Fund 39.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AHG -14.29% SNYR -96.15% Spread: +46.46 pp (AHG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AHG TTM Op. Margin: -28.9% SNYR TTM Op. Margin: -10.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AHG vs SNYR. Trailing 12-month operating profitability (AHG -28.9% vs SNYR -10.3%) and valuation multiples (AHG N/M vs SNYR 0.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AHG (5) vs SNYR (5)
Institutional Metric AHG SNYR Criterion Row Winner
Market Capitalization Scale $1.1B $4.1M Larger Scale AHG
Trailing P/E Ratio Valuation N/M 0.6x Lower Multiple SNYR
Forward P/E Ratio Valuation N/M 0.6x Lower Multiple SNYR
Revenue Growth (YoY) Growth -12.9% -32.8% Higher Growth AHG
Operating Margin (TTM) Profitability -28.9% -10.3% Higher Margin SNYR
Net Profit Margin Profitability -135.0% -57.0% Higher Margin SNYR
Return on Equity (ROE) Capital Efficiency -9.8% -361.1% Higher ROE AHG
52-Week Range Position Momentum 32% ($1โ€“$2) 1% ($0โ€“$3) Stronger Trend AHG
Beta / 30D Volatility Risk Regime 0.38ฮฒ ยท 101% Vol -0.86ฮฒ ยท 868% Vol Lower Realized Risk AHG
Unified Institutional Score Composite Signal 38.2 / 100 (SELL) 48.9 / 100 (HOLD) Higher Composite SNYR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AHG vs SNYR Buy Guide
AHG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AHG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SNYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SNYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AHG nor SNYR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.